Targeted therapy for lung cancer

Meert Anne-Pascale, Cadranel Jacques

Source: Eur Respir J 2015; 46: 1239-1241
Journal Issue: November

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Meert Anne-Pascale, Cadranel Jacques. Targeted therapy for lung cancer. Eur Respir J 2015; 46: 1239-1241

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Targeted therapy in non-small cell lung cancer
Source: Breathe 2012; 8: 206-215
Year: 2012

Successful targeted therapy of advanced lung cancer
Source: Annual Congress 2013 –Grand Round on diagnostic and therapeutic challenges in thoracic oncology: an interactive session
Year: 2013


Advances in target therapy for lung cancer
Source: International Congress 2014 – Ceremony for the ERS Romain Pauwels Research Award 2014 - Clinical Year in Review I
Year: 2014



Advances in target therapy in lung cancer
Source: Eur Respir Rev 2015; 24: 23-29
Year: 2015



Targeted therapies: detrimental treatment for nonsmall cell lung cancer without driver mutations
Source: Eur Respir J 2015; 46: 19-21
Year: 2015


Surgical treatment of nonsmall cell lung cancer
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=170
Year: 2001

Possibilities of palliative combined therapy for extensive nonsmall cells lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 378s
Year: 2001

Targeted therapy for nonsmall cells
Source: Annual Congress 2007 - NSCC - Targeted therapy for nonsmall cells
Year: 2007

Second-line combination therapies in nonsmall cell lung cancer without known driver mutations
Source: Eur Respir Rev 2015; 24: 582-593
Year: 2015



Resistance to chemotherapy in lung cancer
Source: International Congress 2015 – Resistance to therapy in lung cancer
Year: 2015



Immunotherapies for lung cancer
Source: International Congress 2018 – ME12 Immunotherapies for lung cancer FULLY BOOKED
Year: 2018


Radiotherapy in the treatment of nonsmall cell lung cancer
Source: Eur Respir Mon; 2009: 44: 207–243
Year: 2009

Second-line therapy in elderly patients with advanced nonsmall cell lung cancer
Source: Eur Respir J 2014; 43: 240-249
Year: 2004



Therapeutic options targeting angiogenesis in nonsmall cell lung cancer
Source: Eur Respir Rev 2014; 23: 79-91
Year: 2014



Innovative systemic lung cancer therapies
Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy
Year: 2018


Biological therapies in nonsmall cell lung cancer
Source: Eur Respir J , 49 (3) 1601520; DOI: 10.1183/13993003.01520-2016
Year: 2017



Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018

Anticancer treatment for advanced non-small cell lung cancer
Source: Breathe 2011; 8: 124-133
Year: 2011


Innovative local therapies in lung cancer
Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy
Year: 2018


Towards personalized treatment in non-small-cell lung carcinoma
Source: Virtual Congress 2020 – Management issues in thoracic oncology
Year: 2020